Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $8.92

0.23 (+2.66%)

POWR Rating

Component Grades

Buy & Hold

F

Peer

D

Add CNCR to Watchlist
Sign Up

Category: Health & Biotech ETFs

Category

D

Ranked

#31 of 42

in category

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $8.92 52-week high $16.27
Prev. close $8.69 52-week low $7.88
Day low $8.88 Volume 500
Day high $8.92 Avg. volume 2,620
50-day MA $9.69 Dividend yield N/A
200-day MA $12.74

CNCR Stock Price Chart Interactive Chart >


Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

CNCR ETF Info

Issuer Range ETFs
Expense Ratio 0.79%
Underlying Index Range Cancer Therapeutics Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 6.96M
Net Asset Value (NAV) $8.92
Options? Yes
Total Holdings N/A

CNCR Top Holdings

Symbol Company % of Total
%
%
%
%
%
%
%
%
%
%

CNCR Price Returns

1-mo 0.56%
3-mo -29.82%
6-mo -33.38%
1-year -41.58%
3-year -39.93%
5-year -62.83%
YTD -27.54%
2024 -8.61%
2023 -1.89%
2022 -42.31%
2021 -19.24%
2020 36.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!